It’s a BTK inhibitor that’s commonly used for treating MCL, CLL, and Waldenström’s macroglobulinemia. Ibrutinib is available as 140 mg capsules or tablets. You’re typically meant to take between 420 and 560 mg every day.
The tablet form is made to be taken by mouth, and a typical bottle holds around 90 pills. Ibrutinib works by stopping BTK, a signal in cancer cells that helps them keep growing and surviving. The pill comes in a way where you only have to take it once per day, making things easier.
Reviews
There are no reviews yet.